Practical therapeutics for skin lesions of Japanese patients with discoid lupus erythematosus

Bibliography

• Sontheimer RD. The lexicon of cutaneous lupus erythematosus--a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 1997;6:84-95
   PubMedGoogle Scholar
• Furukawa F. Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus. Histol Histopathol 1999;14:627-33
   Google Scholar
• Furukawa F, Tokura Y, Matsushita K, et al. Selective expansions of T cells expressing Vbeta 8 and Vbeta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus. J Dermatol 1996;23:670-6
   PubMedGoogle Scholar
• Koide M, Furukawa F, Wakita H, et al. Soluble form of vascular cell adhesion molecule-1 in systemic lupus erythematosus and discoid lupus erythematosus. J Dermatol Sci 1996;12:73-5
   Google Scholar
• Mikita N, Ikeda T, Ishiguro M, Furukawa F. Recent advances in cytokines in cutaneous and systemic lupus erythematosus. J Dermatol 2011;38:839-49
   PubMed Web of Science ®Google Scholar
• Marin GC, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol 2009;15:325-9
   Google Scholar
• Kuhn A, Ruland V, Bonsmann G. Cutaneous lupus erythematosus: update of therapeutic options part I. J Am Acad Dermatol 2011;65:e179-93
   PubMedGoogle Scholar
• Chang AY, Werth VP. Treatment of cutaneous lupus. Curr Rheumatol Rep 2011;13:300-7
   PubMed Web of Science ®Google Scholar
• Ito T, Seo N, Yagi H, et al. Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice. J Dermatol Sci 2002;28:198-210
   PubMed Web of Science ®Google Scholar
• Kanauchi H, Imamura S, Takigawa M, Furukawa F. Evaluation of the Japanese-Chinese herbal medicine, kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J Dermatol 1994;21:935-9
   Google Scholar
• Yoshimasu T, Ohtani T, Sakamoto T, et al. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002;12:50-2
   PubMed Web of Science ®Google Scholar
• Ruzicka T, Goerz G. Dapsone in the treatment of lupus erythematosus. Br J Dermatol 1981;104:53-6
   Google Scholar
• Yamada Y, Dekio S, Jidoi J, Ozasa S. Lupus erythematosus profundus–report of a case treated with dapsone. J Dermatol 1989;16:379-82
   Google Scholar
• Tohyama M, Hashimoto K. New aspects of drug-induced hypersensitivity syndrome. J Dermatol 2011;38:222-8
   Google Scholar
• Chen M, Doherty SD, Hsu S. Innovative uses of thalidomide. Dermatol Clin 2010;28:577-86
   PubMedGoogle Scholar
• Cortés-Hernández J, Avila G, Vilardell-Tarrés M, Ordi-Ros J. Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus. Arthritis Res Ther 2012;14:R265. [Epub ahead of print]
   Google Scholar
• Marmor MF, Kellner U, Lai TY, et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011;118:415-22
   PubMed Web of Science ®Google Scholar
• Yokogawa N, Kato Y, Sugii S, Inada S. Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI). Mod Rheumatol 2012;22:249-55
   PubMed Web of Science ®Google Scholar
• Ikeda T, Kanazawa N, Furukawa F. Hydroxychloroquine administration for Japanese lupus erythematosus in Wakayama: a pilot study. J Dermatol 2012;39:531-5
   PubMed Web of Science ®Google Scholar
• Yokogawa N, Tanikawa A, Amagai M, et al. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI). Mod Rheumatol 2013;23:318-22
   PubMed Web of Science ®Google Scholar
• Jessop S, Whitelaw DA, Delamere FM. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev 2009;Oct;7(4):CD002954
   Google Scholar
• Sugano M, Shintani Y, Kobayashi K, et al. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus. J Dermatol 2006;33:887-91
   Google Scholar
• Madan V, August PJ, Chalmers RJ. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study. Clin Exp Dermatol 2010;35:27-30
   Google Scholar
• Furukawa F, Itoh T, Wakita H, et al. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol 1999;118:164-70
   Google Scholar
• Klein R, Moghadam-Kia S, Taylor L, et al. Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol 2011;64:849-58
   PubMed Web of Science ®Google Scholar
• Ishiguro M, Hashizume H, Ikeda T, et al. Evaluation of the quality of life in lupus erythematosus patients with cutaneous lesions in Japan. Lupus 2014;23:96-101
   Google Scholar
• Furukawa F, Muto M. Ethnic differences of photosensitivity in cutaneous lupus erythematosus such as discoid lupus erythematosus or subacute cutaneous lupus erythematosus. Arch Dermatol Res 2009;301:111-15
   Google Scholar
• Furukawa F, Tanaka H, Sekita K, et al. Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res 1984;276:186-94
   PubMed Web of Science ®Google Scholar
• Shimomatsu T, Li H, Ikeda T, et al. The effect of hydroxychloroquine on the lupus erythematosus-like skin lesion in MRL/lpr mice [abstract]. J Invest Dermatol 2013;113(Suppl 1):S34
   Google Scholar